Iatrogenic fungal meningitis: Tragedy repeated

Annals of Internal Medicine

Volumn 157, Issue 11, 2012, Pages 825-827

  Perfect, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE ACETATE; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; DRUG CONTAMINATION; ENVIRONMENT; FUNGAL MENINGITIS; HUMAN; INCUBATION TIME; INSTRUMENT STERILIZATION; PRIORITY JOURNAL;

EID: 84870478895     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-11-201212040-00558     Document Type: Article

References (4)

1. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy-United States, July-November 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1109-1112.[PMID: 12530707]
2. Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology. 1994;140:2475-2479. [PMID: 7952197]
3. Schwartz S, Ruhnke M, Ribaud P, Corey L, Driscoll T, Cornely OA, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood. 2005;106:2641-2645.[PMID: 15998833]
4. Weiler S, Fiegl D, MacFarland R, Stienecke E, Bellmann-Weiler R, Dun-zendorfer S, et al. Human tissue distribution of voriconazole. Antimicrob Agents Chemother. 2011;55:925-928. [PMID: 21078931]